Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057767029> ?p ?o ?g. }
- W2057767029 endingPage "294" @default.
- W2057767029 startingPage "288" @default.
- W2057767029 abstract "Recombinant adeno-associated virus (rAAV) is a promising gene delivery vector and has recently been used in patients with hemophilia. One limitation of AAV application is that most humans have experienced wild-type AAV serotype 2 exposure, which frequently generates neutralizing antibodies (NAbs) that may inhibit rAAV2 vector transduction. Employing alternative serotypes of rAAV vectors may circumvent this problem. We investigated the development of NAbs in early childhood by examining sera gathered prospectively from 62 children with hemophilia A, participating in a multi-institutional hemophilia clinical trial (the Joint Outcome Study). Clinical applications in hemophilia therapy have been suggested for serotypes AAV2, AAV5 and AAV8, therefore NAbs against these serotypes were serially assayed over a median follow-up of 4 years. NAbs prevalence increased during early childhood for all serotypes. NAbs against AAV2 (43.5%) were observed more frequently and at higher titers compared with both AAV5 (25.8%) and AAV8 (22.6%). NAbs against AAV5 or AAV8 were rarely observed in the absence of co-prevalent and higher titer AAV2 NAbs, suggesting that NAbs to AAV5 and AAV8 were detected following AAV2 exposure due to partial cross-reactivity of AAV2-directed NAbs. The results may guide rational design of clinical trials using alternative AAV serotypes and suggest that younger patients who are given AAV gene therapy will benefit from the lower prevalence of NAbs." @default.
- W2057767029 created "2016-06-24" @default.
- W2057767029 creator A5001083808 @default.
- W2057767029 creator A5002917649 @default.
- W2057767029 creator A5011549846 @default.
- W2057767029 creator A5014574160 @default.
- W2057767029 creator A5018280451 @default.
- W2057767029 creator A5019219512 @default.
- W2057767029 creator A5020640329 @default.
- W2057767029 creator A5020726409 @default.
- W2057767029 creator A5023583996 @default.
- W2057767029 creator A5023664159 @default.
- W2057767029 creator A5026894111 @default.
- W2057767029 creator A5036325117 @default.
- W2057767029 creator A5038535078 @default.
- W2057767029 creator A5038597185 @default.
- W2057767029 creator A5040151124 @default.
- W2057767029 creator A5042380319 @default.
- W2057767029 creator A5044065218 @default.
- W2057767029 creator A5047634551 @default.
- W2057767029 creator A5051301363 @default.
- W2057767029 creator A5053810912 @default.
- W2057767029 creator A5053864014 @default.
- W2057767029 creator A5063823763 @default.
- W2057767029 creator A5067096441 @default.
- W2057767029 creator A5068003140 @default.
- W2057767029 creator A5068229224 @default.
- W2057767029 creator A5069613263 @default.
- W2057767029 creator A5071684654 @default.
- W2057767029 creator A5079896379 @default.
- W2057767029 creator A5080646091 @default.
- W2057767029 creator A5088383943 @default.
- W2057767029 creator A5088606219 @default.
- W2057767029 creator A5089764896 @default.
- W2057767029 creator A5091296832 @default.
- W2057767029 creator A5091722028 @default.
- W2057767029 creator A5070979768 @default.
- W2057767029 date "2011-06-23" @default.
- W2057767029 modified "2023-10-10" @default.
- W2057767029 title "Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia" @default.
- W2057767029 cites W1907043719 @default.
- W2057767029 cites W1943985333 @default.
- W2057767029 cites W1950013291 @default.
- W2057767029 cites W1975528602 @default.
- W2057767029 cites W1976329054 @default.
- W2057767029 cites W1988197108 @default.
- W2057767029 cites W1990441318 @default.
- W2057767029 cites W2004983645 @default.
- W2057767029 cites W2010388612 @default.
- W2057767029 cites W2013534167 @default.
- W2057767029 cites W2014018178 @default.
- W2057767029 cites W2046488302 @default.
- W2057767029 cites W2047608515 @default.
- W2057767029 cites W2050355069 @default.
- W2057767029 cites W2052186992 @default.
- W2057767029 cites W2052219470 @default.
- W2057767029 cites W2055962386 @default.
- W2057767029 cites W2057548071 @default.
- W2057767029 cites W2058094186 @default.
- W2057767029 cites W2063056703 @default.
- W2057767029 cites W2065451039 @default.
- W2057767029 cites W2067204822 @default.
- W2057767029 cites W2079017842 @default.
- W2057767029 cites W2082025265 @default.
- W2057767029 cites W2082927803 @default.
- W2057767029 cites W2086866768 @default.
- W2057767029 cites W2096309023 @default.
- W2057767029 cites W2113082692 @default.
- W2057767029 cites W2116885047 @default.
- W2057767029 cites W2130515212 @default.
- W2057767029 cites W2140698836 @default.
- W2057767029 cites W2145365087 @default.
- W2057767029 cites W2148223197 @default.
- W2057767029 cites W2151514148 @default.
- W2057767029 cites W2157900284 @default.
- W2057767029 cites W2158522626 @default.
- W2057767029 cites W2167801052 @default.
- W2057767029 cites W2170205772 @default.
- W2057767029 cites W2170614901 @default.
- W2057767029 doi "https://doi.org/10.1038/gt.2011.90" @default.
- W2057767029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21697954" @default.
- W2057767029 hasPublicationYear "2011" @default.
- W2057767029 type Work @default.
- W2057767029 sameAs 2057767029 @default.
- W2057767029 citedByCount "176" @default.
- W2057767029 countsByYear W20577670292012 @default.
- W2057767029 countsByYear W20577670292013 @default.
- W2057767029 countsByYear W20577670292014 @default.
- W2057767029 countsByYear W20577670292015 @default.
- W2057767029 countsByYear W20577670292016 @default.
- W2057767029 countsByYear W20577670292017 @default.
- W2057767029 countsByYear W20577670292018 @default.
- W2057767029 countsByYear W20577670292019 @default.
- W2057767029 countsByYear W20577670292020 @default.
- W2057767029 countsByYear W20577670292021 @default.
- W2057767029 countsByYear W20577670292022 @default.
- W2057767029 countsByYear W20577670292023 @default.
- W2057767029 crossrefType "journal-article" @default.